Individualizing a Drug Court Treatment Plan
Rosa, 38, is a Spanish-dominant mother of three children ages 4, 7, and 9. She has severe opioid use disorder (daily intranasal fentanyl) and was stabilized on buprenorphine 16 mg daily eight weeks ago. Her drug court case plan mandates a 28-day residential program, 90 NA meetings in 90 days, and no contact with her sister, who uses methamphetamine. Rosa works nights cleaning offices, cares for her children, and relies on her mother, who has limited mobility. She has one prior overdose reversed with naloxone six months ago, no prior treatment, and a PHQ-9 score of 14. She says residential placement would cost her job and possibly custody, and she is motivated to stay in treatment. The agency has no Spanish-speaking residential bed within 60 miles, but it offers intensive outpatient three evenings a week with medication management and a bilingual counselor.
1. Recommend a level of care using ASAM dimensions and justify any deviation from the mandated residential placement.
Read the worked answer
ASAM requires an individualized dimensional match, not automatic acceptance of the mandated residential level. Dimension 1: Rosa is medically stable on buprenorphine but needs withdrawal and medication monitoring. Dimension 2: PHQ-9 of 14 indicates moderate depression requiring psychiatric assessment. Dimension 3: she has no current intoxication or withdrawal but has severe SUD and prior overdose, so relapse risk is high. Dimension 4: she is motivated and engaged. Dimension 5: relapse potential is significant but can be managed with medication and frequent contacts. Dimension 6: her recovery environment is mixed - children and mother are stabilizing, work is prosocial, but her sister uses. Residential would remove her from her children, jeopardize her job, and place her 60 miles from the only Spanish-speaking services; it is not the least restrictive appropriate level. I would recommend Level 2.1 intensive outpatient three evenings weekly with buprenorphine management, bilingual counseling, psychiatric care, and random testing, and document this rationale to the court. The court may mandate treatment, but the clinical recommendation must be defensible.
2. How would you modify the 90-meetings-in-90-days requirement in a clinically sound and culturally responsive way?
Read the worked answer
90 meetings in 90 days is a common court expectation, not an evidence-based requirement, and NA is not the only acceptable mutual-aid option. A rigid mandate can set Rosa up to fail, especially with night work and three children. I would propose a modified plan: three IOP sessions weekly, one bilingual peer-support or SMART Recovery group, and two AA/NA or faith-based meetings she chooses, for a scheduled weekly dose she can actually sustain, with attendance documented. I would assess her sister's role rather than impose a no-contact rule automatically: if the sister provides childcare or transport, an absolute ban may increase risk. A family session could establish boundaries - no using in Rosa's home, no sharing substances - while preserving needed support. I would explain the rationale to the court and to Rosa, provide Spanish-language schedules, arrange childcare and transport vouchers, and measure engagement by attendance, participation, and urine results rather than by counting meetings alone. The plan should be reviewed in 30 days and adjusted.
3. What case management and monitoring tasks belong in the plan, and how should a positive drug test be handled?
Read the worked answer
Case management should coordinate the buprenorphine prescriber, psychiatric evaluation, child welfare, and the court, with a signed specific release for each. I would arrange random observed urine testing, naloxone and overdose education for Rosa and her mother, and a written relapse plan that names who she calls and where the children go if she relapses. I would document the ASAM rationale, the court negotiation, language access, childcare and transport barriers, and the 30-day review. If a positive test occurs, the response should be a clinical reassessment rather than automatic discharge or punishment - consider increased IOP, medication adjustment, or residential if safety worsens. I would also clarify my role to Rosa: I am not the court's investigator and will share only what the release permits. Progress should be measured by multiple indicators, not a single urine result.